Insider screener

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,134 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,134 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,134 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,134 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,134 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,134 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,134 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Jan 2026
HOLMES NED S Director · indirect
Sold on a plan 4×
$44.57K 600 at 74.29
1.4%
Planned (10b5-1)
21 Jan 2026
SMITH J. JEFFERSON Chief Research Officer
Sold on a plan
$41.11K 10,200 at 4.03
8.5%
Planned (10b5-1)
21 Jan 2026
Roberts Zachary EVP of R&D
Sold at will
$40.98K 26,269 at 1.56
4.1%
Not planned
21 Jan 2026
Walsh Paul V Jr Director
Sold on a plan
$39.13K 500 at 78.25
1.9%
Planned (10b5-1)
21 Jan 2026
HOLMES NED S Director
Sold on a plan 2×
$37.14K 500 at 74.29
0.6%
Planned (10b5-1)
21 Jan 2026
Scimeca Dario General Counsel and Secretary
Sold on a plan
$35.68K 8,854 at 4.03
16.5%
Planned (10b5-1)
21 Jan 2026
Lehner Edward J. President & CEO
Sold on a plan
$30.01K 1,000 at 30.01
0.2%
Planned (10b5-1)
21 Jan 2026
Gleason Shane Thomas Chief Commercial Officer
Sold at will
$28.55K 17,593 at 1.62
1.5%
Not planned
21 Jan 2026
Cree Brian President
Sold on a plan
$28.36K 1,440 at 19.69
0.3%
Planned (10b5-1)
21 Jan 2026
Agwunobi John O Director
Sold on a plan
$26.03K 146 at 178.31
1.6%
Planned (10b5-1)
21 Jan 2026
Platzer Peter Executive Chairman
Sold on a plan
$21.79K 1,801 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
Sold on a plan
$20.50K 25,000 at 0.82
14.3%
Planned (10b5-1)
21 Jan 2026
Kirol Charles Peter Chief Operating Officer
Sold on a plan
$19.90K 3,399 at 5.85
4.2%
Planned (10b5-1)
21 Jan 2026
OConnell Daniel Joseph Chief Executive Officer
Sold at will
$16.93K 9,346 at 1.81
1.0%
Not planned
21 Jan 2026
Eagle Point Credit Management LLC 10% owner · indirect
Sold at will
$15.27K 692 at 22.07
0.1%
Not planned
21 Jan 2026
Condor Theresa Chief Executive Officer
Sold on a plan
$14.53K 1,201 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
Sherry David Chief Financial Officer
Sold on a plan 4×
$12.80K 145 at 88.26
0.0%
Planned (10b5-1)
21 Jan 2026
Trigg Leslie Chair and CEO
Sold at will
$10.71K 2,120 at 5.05
2.0%
Not planned
21 Jan 2026
Sold at will
$10.24K 7,512 at 1.36
0.3%
Not planned
21 Jan 2026
Wu Lei Chief Executive Officer · indirect
Sold on a plan
$8.45K 210 at 40.26
0.0%
Planned (10b5-1)
21 Jan 2026
Moreadith Randall Chief Scientific Officer
Sold on a plan
$6.00K 2,000 at 3.00
100%
Sold half or more
21 Jan 2026
Brottem John L. General Counsel
Sold at will
$5.91K 1,180 at 5.01
3.2%
Not planned
21 Jan 2026
Nash Marc EVP Operations R&D & Service
Sold at will
$4.88K 980 at 4.98
2.3%
Not planned
21 Jan 2026
Zuga Matt CFO & Chief Business Officer
Sold at will
$4.47K 2,473 at 1.81
0.8%
Not planned
21 Jan 2026
Siemers Eric Chief Medical Officer
Sold at will
$4.20K 2,331 at 1.80
0.9%
Not planned
21 Jan 2026
Hanna John Walter JR President and CEO
Sold on a plan
$4.20K 200 at 21.00
0.0%
Planned (10b5-1)
21 Jan 2026
Barton Russell Chief Operating Officer
Sold at will
$4.18K 2,315 at 1.81
1.1%
Not planned
21 Jan 2026
Meisner Derek M Chief Legal Officer & Corp Sec
Sold at will
$4.06K 2,247 at 1.81
1.2%
Not planned
21 Jan 2026
Abate Kristin Chief Accounting Officer
Sold at will
$1.58K 265 at 5.96
1.2%
Not planned
21 Jan 2026
GAVRIELOV MOSHE Director
Sold at will
$1.56K 5 at 312.56
0.5%
Not planned
20 Jan 2026
Slootman Frank Director
Sold on a plan 5×
$41.35M 200,000 at 206.77
79.9%
Sold half or more
20 Jan 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$16.89M 71,932 at 234.74
24.9%
Planned (10b5-1)
20 Jan 2026
SCHOTTENSTEIN JAY L Exec Chairman & CEO · indirect
Sold at will
$12.64M 500,000 at 25.27
6.7%
Not planned
20 Jan 2026
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 28×
$10.45M 22,500 at 464.66
100%
Sold half or more
20 Jan 2026
McBee Brannin Chief Development Officer
Sold on a plan 5×
$9.80M 102,835 at 95.29
29.3%
Planned (10b5-1)
20 Jan 2026
Biswas Sanjit CHIEF EXECUTVE OFFICER · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
Bicket John SEE REMARKS · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
Wong Jennifer L. Chief Operating Officer
Sold on a plan 9×
$6.13M 27,159 at 225.73
2.3%
Planned (10b5-1)
20 Jan 2026
McBee Brannin Chief Development Officer · indirect
Sold on a plan 35×
$6.08M 63,835 at 95.29
100%
Sold half or more
20 Jan 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$5.62M 23,948 at 234.74
19.4%
Planned (10b5-1)
20 Jan 2026
SAPERSTEIN ANDREW M Co-President
Sold at will 6×
$5.57M 30,330 at 183.62
9.8%
Not planned
20 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$5.45M 23,205 at 234.74
13.8%
Planned (10b5-1)
20 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$4.51M 19,234 at 234.74
7.8%
Planned (10b5-1)
20 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$4.18M 17,806 at 234.74
9.1%
Planned (10b5-1)
20 Jan 2026
Bialecki Andrew Co-Chief Executive Officer
Sold on a plan 2×
$4.06M 167,926 at 24.16
100%
Sold half or more
20 Jan 2026
GROSSMAN ERIC F Chief Legal/Admin Officer
Sold at will
$3.97M 21,555 at 184.00
11.2%
Not planned
20 Jan 2026
Duda Kenneth President and CTO
Sold on a plan 4×
$3.85M 30,000 at 128.43
69.8%
Sold half or more
20 Jan 2026
Pizzi Michael A. Head Technology & Operations
Sold at will
$3.69M 20,000 at 184.55
13.5%
Not planned
20 Jan 2026
Mat Ishbia President and CEO · indirect
Sold on a plan
$3.68M 632,874 at 5.82
9.6%
Planned (10b5-1)
20 Jan 2026
Duda Kenneth President and CTO · indirect
Sold on a plan 8×
$3.34M 26,000 at 128.43
4.7%
Planned (10b5-1)
Showing 35,401–35,450 of 46,134. ← Newer Page 709 of 923 Older →